Long-term outcome following pediatric liver transplantation for metabolic disorders

Terrell Stevenson1, Maria T Millan, Karen Wayman

  • 1Department of Surgery, Stanford University, Stanford, CA, USA.

Insights

Pediatric liver transplantation offers excellent survival and improved growth for children with metabolic disorders. While psychomotor development enhances, cognitive skills remain in the low-normal range post-transplant.

Area of Science:

  • Pediatric Hepatology
  • Metabolic Disorders
  • Transplantation Immunology

Background:

  • Metabolic disorders can lead to severe liver dysfunction in children.
  • Liver transplantation is a potential treatment, but long-term outcomes require evaluation.

Purpose of the Study:

  • To assess long-term survival, growth, and neurodevelopmental outcomes in children with metabolic disorders following liver transplantation.

Main Methods:

  • Retrospective chart review of 54 children with metabolic disorders evaluated between 1989-2005.
  • Analysis of presenting symptoms, transplant details, survival rates, metabolic parameters, and developmental assessments.

Main Results:

  • 33 children underwent liver transplantation (12 with combined liver-kidney).
  • Excellent patient survival (100%) and allograft survival (92-100%) at a median 3.6-year follow-up.
  • Improved weight Z scores and normal BMI; significant psychomotor development gains (p < 0.01), but mental skills remained low-normal.

Conclusions:

  • Liver or combined liver-kidney transplantation is associated with excellent long-term survival in pediatric metabolic disorders.
  • Transplantation improves growth and psychomotor development, though cognitive function may lag.
  • Outcomes comparable to biliary atresia patients for psychomotor development, but lower for mental skills.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...